Weldinide F Respules (2ml Each) is a combination inhalation solution containing Formoterol fumarate dihydrate (20 mcg/2 ml) and Budesonide (0.5 mg/2 ml), indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Formoterol is a long-acting beta2-adrenergic agonist (LABA) that provides bronchodilation by relaxing airway smooth muscle, resulting in improved airflow and symptom relief. Budesonide is a corticosteroid with potent anti-inflammatory properties that reduce airway inflammation, edema, and hyperresponsiveness. The synergistic action of these agents helps control and prevent symptoms such as wheezing, shortness of breath, and coughing. Administered via nebulization, Weldinide F Respules deliver medication directly to the lungs, ensuring rapid onset and enhanced local efficacy with minimal systemic exposure. This product is intended for regular use as prescribed by a healthcare professional and is not suitable for acute bronchospasm relief. Patients should adhere to prescribed dosing schedules and consult their physician if symptoms worsen or if they experience adverse effects such as tremors, palpitations, or oral candidiasis. Weldinide F Respules are contraindicated in patients with hypersensitivity to either component and should be used cautiously in individuals with cardiovascular disorders or diabetes.